Chronic treatment with typical and atypical antipsychotics increases the AMPA-preferring form of AMPA receptor in rat brain
Open Access
- 1 December 1996
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 318 (1) , 41-45
- https://doi.org/10.1016/s0014-2999(96)00910-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrainNeuroscience Letters, 1996
- Effects of typical and atypical antipsychotics on AMPA site bindingBiological Psychiatry, 1996
- Interactions between excitatory amino acids and dopamine systems in the forebrainBehavioural Pharmacology, 1995
- Chronic effects of typical and atypical neuroleptics on glutamate receptor subtypesSchizophrenia Research, 1995
- Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatmentJournal of Psychopharmacology, 1994
- Postnatal changes in AMPA receptor regulation by phospholipase A2 treatment of synaptic membranes: temporally differential effects on agonist and antagonist bindingDevelopmental Brain Research, 1992
- Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristicsBrain Research, 1991
- Decreased hippocampal expression of a glutamate receptor gene in schizophreniaThe Lancet, 1991
- Autoradiographic Characterization and Localization of Quisqualate Binding Sites in Rat Brain Using the Antagonist [3H]6‐Cyano‐7‐Nitroquinoxaline‐2,3‐Dione: Comparison with (R,S)‐[3H]α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding SitesJournal of Neurochemistry, 1990
- Thiocyanate stabilizes AMPA binding to the quisqualate receptorEuropean Journal of Pharmacology, 1988